FindTestingLabs

Registers refreshed 2026-09-25.See refresh dates

Türkiye

Kobay Deney Hayvanlari Laboratuari San. ve Tic.

Uzaycagi Caddesi 1308. Sokak No:16 Yenimahalle, Ostim ODTU Teknokent, Ankara, 06100, Turkey, Ankara, Türkiye

A2LA|7072.01ISO/IEC 17025Register refreshed 2026-09-25

Certificates

1

Scope items

3

Standards

13

Locations

1

Free. We check which accredited labs can do it, starting with this one, and reply within two working days with who can do it, how fast, and roughly what it costs.

Only the laboratory you pick gets your contact details. We ask the others without them.

Contact this laboratory

begum@kobay.com.tr

Open A2LA register entry

Work at Kobay Deney Hayvanlari Laboratuari San. ve Tic.?

Claim this profile to keep it accurate.

Register record

A2LARefreshed 2026-09-25: 7072.01Active

Accredited standards

13

Our reading of the A2LA scope: each standard once, with its official name where we have checked it. Click a standard to see the scope line it comes from, word for word.

ISO 10993 series

ISO 10993-2Biological evaluation of medical devices - Part 2: Animal welfare requirements

As written on the certificate · Line 1 (A2LA 7072.01)

OECD TG 404; OECD TG 471; TS EN ISO 10993-12; ISO 10993-12; TS EN ISO 10993-3; ISO 10993-3; OECD TG 487; TS EN ISO 10993-5; ISO 10993-5; TS EN ISO 10993-4; ISO 10993-4; European Pharmacopoeia 10.0 (2.6.8); TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-23; ISO 10993-23; TS EN ISO 10993-6; ISO 10993-6; TS EN ISO 10993-10

As written on the certificate · Line 2 (A2LA 7072.01)

ISO 10993-10; TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-11; ISO 10993-11; TS EN ISO 10993-12; ISO 10993-12; ISO 11737-2; USP 42 NF 37; European Pharmacopoeia 2.6.14; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 17294-1; ISO 10993-18; ISO 10993-12

ISO 10993-3Biological evaluation of medical devices - Part 3: Evaluation of genotoxicity, carcinogenicity, reproductive toxicity and developmental toxicity

As written on the certificate · Line 1 (A2LA 7072.01)

OECD TG 404; OECD TG 471; TS EN ISO 10993-12; ISO 10993-12; TS EN ISO 10993-3; ISO 10993-3; OECD TG 487; TS EN ISO 10993-5; ISO 10993-5; TS EN ISO 10993-4; ISO 10993-4; European Pharmacopoeia 10.0 (2.6.8); TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-23; ISO 10993-23; TS EN ISO 10993-6; ISO 10993-6; TS EN ISO 10993-10

ISO 10993-4Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood

As written on the certificate · Line 1 (A2LA 7072.01)

OECD TG 404; OECD TG 471; TS EN ISO 10993-12; ISO 10993-12; TS EN ISO 10993-3; ISO 10993-3; OECD TG 487; TS EN ISO 10993-5; ISO 10993-5; TS EN ISO 10993-4; ISO 10993-4; European Pharmacopoeia 10.0 (2.6.8); TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-23; ISO 10993-23; TS EN ISO 10993-6; ISO 10993-6; TS EN ISO 10993-10

ISO 10993-5Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity

As written on the certificate · Line 1 (A2LA 7072.01)

OECD TG 404; OECD TG 471; TS EN ISO 10993-12; ISO 10993-12; TS EN ISO 10993-3; ISO 10993-3; OECD TG 487; TS EN ISO 10993-5; ISO 10993-5; TS EN ISO 10993-4; ISO 10993-4; European Pharmacopoeia 10.0 (2.6.8); TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-23; ISO 10993-23; TS EN ISO 10993-6; ISO 10993-6; TS EN ISO 10993-10

ISO 10993-6Biological evaluation of medical devices - Part 6: Tests for local effects after implantation

As written on the certificate · Line 1 (A2LA 7072.01)

OECD TG 404; OECD TG 471; TS EN ISO 10993-12; ISO 10993-12; TS EN ISO 10993-3; ISO 10993-3; OECD TG 487; TS EN ISO 10993-5; ISO 10993-5; TS EN ISO 10993-4; ISO 10993-4; European Pharmacopoeia 10.0 (2.6.8); TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-23; ISO 10993-23; TS EN ISO 10993-6; ISO 10993-6; TS EN ISO 10993-10

ISO 10993-10Biological evaluation of medical devices - Part 10: Tests for skin sensitization

As written on the certificate · Line 1 (A2LA 7072.01)

OECD TG 404; OECD TG 471; TS EN ISO 10993-12; ISO 10993-12; TS EN ISO 10993-3; ISO 10993-3; OECD TG 487; TS EN ISO 10993-5; ISO 10993-5; TS EN ISO 10993-4; ISO 10993-4; European Pharmacopoeia 10.0 (2.6.8); TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-23; ISO 10993-23; TS EN ISO 10993-6; ISO 10993-6; TS EN ISO 10993-10

As written on the certificate · Line 2 (A2LA 7072.01)

ISO 10993-10; TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-11; ISO 10993-11; TS EN ISO 10993-12; ISO 10993-12; ISO 11737-2; USP 42 NF 37; European Pharmacopoeia 2.6.14; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 17294-1; ISO 10993-18; ISO 10993-12

ISO 10993-11Biological evaluation of medical devices - Part 11: Tests for systemic toxicity

As written on the certificate · Line 2 (A2LA 7072.01)

ISO 10993-10; TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-11; ISO 10993-11; TS EN ISO 10993-12; ISO 10993-12; ISO 11737-2; USP 42 NF 37; European Pharmacopoeia 2.6.14; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 17294-1; ISO 10993-18; ISO 10993-12

ISO 10993-12Biological evaluation of medical devices - Part 12: Sample preparation and reference materials

As written on the certificate · Line 1 (A2LA 7072.01)

OECD TG 404; OECD TG 471; TS EN ISO 10993-12; ISO 10993-12; TS EN ISO 10993-3; ISO 10993-3; OECD TG 487; TS EN ISO 10993-5; ISO 10993-5; TS EN ISO 10993-4; ISO 10993-4; European Pharmacopoeia 10.0 (2.6.8); TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-23; ISO 10993-23; TS EN ISO 10993-6; ISO 10993-6; TS EN ISO 10993-10

As written on the certificate · Line 2 (A2LA 7072.01)

ISO 10993-10; TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-11; ISO 10993-11; TS EN ISO 10993-12; ISO 10993-12; ISO 11737-2; USP 42 NF 37; European Pharmacopoeia 2.6.14; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 17294-1; ISO 10993-18; ISO 10993-12

ISO 10993-18Biological evaluation of medical devices - Part 18: Chemical characterization of medical device materials within a risk management process

As written on the certificate · Line 2 (A2LA 7072.01)

ISO 10993-10; TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-11; ISO 10993-11; TS EN ISO 10993-12; ISO 10993-12; ISO 11737-2; USP 42 NF 37; European Pharmacopoeia 2.6.14; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 17294-1; ISO 10993-18; ISO 10993-12

ISO 10993-23Biological evaluation of medical devices - Part 23: Tests for irritation

As written on the certificate · Line 1 (A2LA 7072.01)

OECD TG 404; OECD TG 471; TS EN ISO 10993-12; ISO 10993-12; TS EN ISO 10993-3; ISO 10993-3; OECD TG 487; TS EN ISO 10993-5; ISO 10993-5; TS EN ISO 10993-4; ISO 10993-4; European Pharmacopoeia 10.0 (2.6.8); TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-23; ISO 10993-23; TS EN ISO 10993-6; ISO 10993-6; TS EN ISO 10993-10

Other standards

ISO 11737-2Sterilization of health care products - Microbiological methods - Part 2: Tests of sterility performed in the definition, validation and maintenance of a sterilization process

As written on the certificate · Line 2 (A2LA 7072.01)

ISO 10993-10; TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-11; ISO 10993-11; TS EN ISO 10993-12; ISO 10993-12; ISO 11737-2; USP 42 NF 37; European Pharmacopoeia 2.6.14; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 17294-1; ISO 10993-18; ISO 10993-12

ISO 17294-1Water quality - Application of inductively coupled plasma mass spectrometry (ICP-MS) - Part 1: General requirements

As written on the certificate · Line 2 (A2LA 7072.01)

ISO 10993-10; TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-11; ISO 10993-11; TS EN ISO 10993-12; ISO 10993-12; ISO 11737-2; USP 42 NF 37; European Pharmacopoeia 2.6.14; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 17294-1; ISO 10993-18; ISO 10993-12

USP 42Name not checked yet

As written on the certificate · Line 2 (A2LA 7072.01)

ISO 10993-10; TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-11; ISO 10993-11; TS EN ISO 10993-12; ISO 10993-12; ISO 11737-2; USP 42 NF 37; European Pharmacopoeia 2.6.14; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 17294-1; ISO 10993-18; ISO 10993-12

Scope as published by A2LA

3 lines

A2LA

ISO/IEC 17025

Active

7072.01

The scope document we hold says it is valid until 2026-12-31.

Accredited scope, certificate 7072.01

Line	Discipline	Method	Matrix	Range
1	biological	OECD TG 404; OECD TG 471; TS EN ISO 10993-12; ISO 10993-12; TS EN ISO 10993-3; ISO 10993-3; OECD TG 487; TS EN ISO 10993-5; ISO 10993-5; TS EN ISO 10993-4; ISO 10993-4; European Pharmacopoeia 10.0 (2.6.8); TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-23; ISO 10993-23; TS EN ISO 10993-6; ISO 10993-6; TS EN ISO 10993-10	medical devices, equipment and products	-
2	chemical	ISO 10993-10; TS EN ISO 10993-2; ISO 10993-2; TS EN ISO 10993-11; ISO 10993-11; TS EN ISO 10993-12; ISO 10993-12; ISO 11737-2; USP 42 NF 37; European Pharmacopoeia 2.6.14; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 10993-18; ISO 10993-12; ISO 17294-1; ISO 10993-18; ISO 10993-12	-	-
3	biological	For the tests to which this accreditation applies, please refer to the laboratory’s Biological Scope of Accreditation. Accredited Laboratory A2LA has accredited KOBAY DENEY HAYVANLARI LABORATUARI SAN. VE TIC. AS Ankara, TURKEY for technical competence in the field of Biological Testing This laboratory is accredited in accordance with the recognized International Standard ISO/IEC 17025:2017 General requirements for the competence of testing and calibration laboratories. This accreditation demonstrates technical competence for a defined scope and the operation of a laboratory quality management system (refer to joint ISO-ILAC-IAF Communiqué dated April 2017). Presented this 21st day of October 2025. _______________________ Mr. Trace McInturff, Vice President, Accreditation Services For the Accreditation Council Certificate Number 7072.01 Valid to December 31, 2026

Ranges are reproduced from the accredited scope document as published. An absent range means the register did not state one. Line numbers are ours, for cross-reference; they follow the order of the scope document.

Accreditation data refreshed from the A2LA register on 2026-09-25.

This page mirrors a public register. For a purchasing, audit or regulatory decision, confirm against the A2LA entry linked above.